<seo title="Quest Diagnostics" metakeywords="quest diagnostics founded,diagnostics quest diagnostics,quest diagnostics,quest diagnostics leading" metadescription="Quest Diagnostics is a publicly traded company on the New York Stock Exchange." />
===Introduction to Quest Diagnostics===

Quest Diagnostics is a leading provider of diagnostic testing services in the United States. The company offers a wide range of diagnostic testing services, including laboratory testing, genetic testing, and imaging services. Quest Diagnostics is a publicly traded company on the New York Stock Exchange (NYSE: DGX). The company is headquartered in Madison, New Jersey and has over 45,000 employees.
===History of Quest Diagnostics===

Quest Diagnostics was founded in 1967 as Metropolitan Pathology Laboratory, Inc. The company was founded by Paul Brown and was initially focused on providing laboratory testing services to physicians in the New York City area. In the 1980s, the company expanded its services to include genetic testing and imaging services. In 1995, the company changed its name to Quest Diagnostics and went public on the New York Stock Exchange. Since then, the company has grown to become one of the largest diagnostic testing companies in the United States.
===Services Offered by Quest Diagnostics===

Quest Diagnostics offers a wide range of diagnostic testing services. The company’s services include laboratory testing, genetic testing, and imaging services. Laboratory testing services include blood tests, urine tests, and other tests to diagnose and monitor diseases. Genetic testing services include tests to detect genetic disorders and to identify inherited traits. Imaging services include -rays, CT scans, and MRI scans.
===Financial Performance of Quest Diagnostics===

Quest Diagnostics has had a strong [[Financial Performance|financial performance]] in recent years. The company’s revenue has grown steadily over the past five years, from $7.3 billion in 2015 to $8.7 billion in 2020. The company’s [[Net Income|net income]] has also grown over the same period, from $717 million in 2015 to $1.1 billion in 2020. The company’s stock price has also increased significantly over the past five years, from $77.50 in 2015 to $125.50 in 2020.
===Conclusion===

Quest Diagnostics is a leading provider of diagnostic testing services in the United States. The company offers a wide range of services, including laboratory testing, genetic testing, and imaging services. The company has had a strong financial performance in recent years, with revenue and net income growing steadily and the stock price increasing significantly